This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Humana (HUM) to Support Eligible Medicaid Members in Louisiana
by Zacks Equity Research
Humana (HUM) is picked by the Louisiana Department of Health for a contract win to help serve the Medicaid members in Louisiana.
Centene (CNC) Boosts Presence in Louisiana With Contract Win
by Zacks Equity Research
Centene's (CNC) latest contract renewal tends to improve health outcomes of Medicaid members of Louisiana.
Community Health (CYH) Ties Up to Offer Enhanced Remote Care
by Zacks Equity Research
Community Health (CYH) teams up with Cadence highlighting its aim of utilizing innovative technology to extend enhanced remote care to patients.
Centene (CNC) Q4 Earnings Beat on Solid Membership Growth
by Zacks Equity Research
Centene's (CNC) fourth-quarter results indicate improved premium and service revenues coupled with sound membership growth. A solid 2022 guidance should impress investors.
Centene (CNC) Q4 Earnings Beat Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 3.06% and 0.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Centene (CNC) Gears Up for Q4 Earnings: What Lies Ahead?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are likely to reflect growth in total membership.
Centene (CNC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Group (UNH) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 4.19% and 0.95%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: CF Industries, Exxon Mobil, Tesla, Centene Corp. and Southwest Airlines
by Zacks Equity Research
CF Industries, Exxon Mobil, Tesla, Centene Corp. and Southwest Airlines are included in this analyst blog.
5 S&P 500 Stocks Set to Report Triple-Digits Earnings Growth
by Sweta Killa
S&P 500 stocks like CF Industries (CF), Exxon Mobil (XOM), Tesla (TSLA), Centene (CNC) and Southwest Airlines (LUV) are set to post triple-digit earnings growth when they report.
UnitedHealth (UNH) Unit Invests to Improve Members' Eye Health
by Zacks Equity Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, offers discount programs and invests in school districts in an effort to improve the eye health of its vision members.
Here's Why You Should Retain Centene (CNC) in Your Portfolio
by Zacks Equity Research
Centene (CNC) is well poised for growth on the back of improving revenues, continuous expansion plans for the MA business and sufficient cash-generating abilities.
Humana (HUM) Cuts Medicare Enrollment Outlook, Tumbles 19.4%
by Zacks Equity Research
Humana (HUM) expects Group Medicare Advantage membership to remain flat in 2022, with competitive pricing possibly playing a crucial role.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
by Zacks Equity Research
Sector ETF report for RYH
Humana (HUM) Enhances Value-Based Care With Vancouver Clinic
by Zacks Equity Research
Humana (HUM) collaborates with Vancouver Clinic to boost its Medicare Advantage portfolio.
Molina Healthcare (MOH) Buys Cigna's TX Medicaid Contracts
by Zacks Equity Research
Molina Healthcare (MOH) purchases the Texas Medicaid contracts of Cigna to bolster its presence in the Texas region.
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYH
Centene (CNC) Receives DMHC Approval for Magellan Acquisition
by Zacks Equity Research
Centene's (CNC) acquisition with Magellan Health is likely to close on Jan 4, 2022, around a year after the deal announcement.
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the prospering health insurance industry. On comparative evaluation, we try to discover which stock is more profitable, based on the fundamentals.
Cigna (CI), SRHS Tie Up to Offer Enhanced Care in Upstate SC
by Zacks Equity Research
Cigna (CI) inks a deal to expand ties with SRHS. The move equips both healthcare providers to jointly offer enhanced healthcare services across the Upstate community.
4 Health Insurers Poised to Maintain Winning Streak in 2022
by Kaibalya Pravo Dey
Buoyed by government support and technological improvements, stocks in the health insurance industry are likely to witness increased product demand. UNH, ANTM, CNC & MOH are well positioned to make the most of the market improvement.
Zacks.com featured highlights include: Boise Cascade, Caleres, Centene, Commercial Metals Company and BJ's Wholesale Club
by Zacks Equity Research
Zacks.com featured highlights include: Boise Cascade, Caleres, Centene, Commercial Metals Company and BJ's Wholesale Club
5 Stocks to Keep Tabs on Post Recent Broker Upgrade
by Maharathi Basu
Boise Cascade (BCC), Caleres (CAL), Centene (CNC), Commercial Metals (CMC) and BJ's Wholesale Club (BJ) are some of the broker-friendly stocks to watch out for.
Teladoc (TDOC) Ties Up to Offer Virtual Care for NLA Members
by Zacks Equity Research
Teladoc Health (TDOC) teams up with NLA in a bid to offer its comprehensive suite of virtual care services to benefit the latter's members.
Why Retaining Cigna (CI) Stock for Now is a Prudent Move?
by Zacks Equity Research
Cigna (CI) expects growth of at least 350,000 customers in 2021 to ramp up total medical clients.